PFF in the Media

2018

6.16.18 
San Francisco Business Times: Why investors injected $62 million into a Peninsula biotech targeting a deadly lung disease

5.24.18
HealthNewsReview.org: In portraying a silver lining to Santa Fe school shooting, news stories mislead public about GoFundMe campaign for victim’s husband

3.30.18
Windy City Gridiron: Spurred by personal tragedy, Jordan Howard seeking to change lives

1.10.18
PF Warrior: Meet Bill Schmidt, the new CEO of the Pulmonary Fibrosis Foundation

2017

12.1.17
CBS Chicago: Bears' Jordan Howard A Star to Those With Pulmonary Fibrosis

12.1.17
WGN Radio: Chicago Bears Running Back Jordan Howard on his cleats and his cause

11.24.17
Future of Personal Health: How One Pulmonary Fibrosis Patient Gets by with a Little Help from His Friends

9.23.17
The Times-Tribune: Letters to the Editor 9/23/2017

9.20.17
The Lancet Respiratory Medicine: Validation of a 52-gene risk profile for outcome prediction in patients with idiopathic pulmonary fibrosis: an international, multicentre, cohort study

9.12.17
St. Louis Post-Dispatch: Get involved in fight against pulmonary fibrosis

9.4.17
WGN Radio: September marks Pulmonary Fibrosis Awareness Month

9.3.17
Local SYR: Fundraisers For Pulmonary Fibrosis Coming Up!

9.1.17
Spectrum News: Yankees’ Bernie Williams on Raising Awareness of Fatal Lung Disease

9.1.17
The Press-Enterprise: Hemet woman with lung disease starts support group to help others

8.28.17
Eagle News Online: ‘Make Every Breath Count’ walk to raise money for Pulmonary Fibrosis Foundation

5.29.17
American Thoracic Society: Patients With Lung Disease Say Current Home Oxygen Delivery Systems Do Not Meet Their Needs, Increase Their Isolation

2016

12.22.16
Bleacher Report: Jordan Howard: The Other Rookie RB Taking the NFL by Storm

12.16.16
THE Score: Interview With PFF President and CEO Patti Tuomey

12.13.16
NORD: President Signs 21st Century Cures Medical Innovation Bill Into Law

12.7.16
NORD: Senate Passes Landmark 21st Century Cures Act

12.6.16
WGN9: THE MORNING AFTER: The more you know, in the snow

12.1.16
KOMO Seattle: Man with Terminal Lung Disease Completes Marathon

11.09.16
NBC Chicago: Bears Rookie Jordan Howard Looks to End Late Father's Disease

2015

8.20.15
790 Talk Now Heidi Harris Show: Interview with Dr. Gregory P. Cosgrove on pulmonary fibrosis

03.26.15
St. Louis Post-Dispatch: Lung transplant saves man who had five years to live

03.13.15
ChicagoTribune.com: Feeling short of breath? It could be something serious*

03.12.15
The Bulletin: Drugs for rare disease out of reach for Bend patient

02.05.15
Daily Southtown: Chicago-based Pulmonary Fibrosis Foundation expands first-of-its-kind care center network; care center network program piloted at University of Chicago

01.05.15
WGNU: PFF Radio Media Tour**

*posted by more than 1,100 online publications including Tribune
**interviews aired on more than 13 broadcast outlets nationwide

2014

11.5.14
WGN: Two new drug options give hope to those suffering pulmonary fibrosis

10.17.14
Pulmonary Hypertension News: 2 IPF drugs get FDA approval; Pulmonary Fibrosis Foundation's Praise

10.17.14 
BioWorld: Air pair Esbriet, Ofev tied for FDA first in IPF; Roche rolling price dice but BI yet to disclose

10.16.14
Tech Times: FDA approval of Roche, Boehringer drugs for idiopathic pulmonary fibrosis is a big step forward

10.16.14
The Science Times: FDA approves two separate drugs for killer lung disease

10.16.14
Uncover Michigan: First two drugs for treatment of fatal lung disease approved by FDA

10.16.14
Capital OTC: FDA approves two drugs (Esbriet, Ofev) for treating fatal lung disease

10.16.14
Delhi Daily News: FDA approves first two drugs for fatal lung disease

10.15.14
San Francisco Business Times: InterMune wins FDA OK for lung-scarring disease drug at center of Roche deal

10.15.14
San Francisco Gate: Roche’s InterMune wins FDA approval for lung disease treatment

10.15.14
The Examiner: The FDA has approved two drugs for a fatal lung disease

10.15.14
The Street: FDA approves competing lung disease drugs from Roche and Boehringer